Effects of lipoic acid on migration of human B cells and monocyte-enriched peripheral blood mononuclear cells in relapsing remitting multiple sclerosis

Joshua D. George, Edward Kim, Rebecca Spain, Dennis Bourdette, Sonemany Salinthone

Research output: Contribution to journalArticle

2 Scopus citations


Multiple sclerosis (MS) is a disease of the central nervous system characterized by inflammation and demyelination resulting in clinical disability. The rodent MS model suggests that infiltration of monocytes and B cells contributes to disease pathogenesis. Here, we compared the migratory capacity of human monocytes and B cells from healthy control (HC) and relapsing-remitting MS (RRMS) subjects, with or without lipoic acid (LA) treatment. Basal migration of monocyte-enriched PBMCs from RRMS subjects is significantly higher than HC PBMCs. LA treatment significantly inhibits monocyte and B cell migration in both cohorts, and may thus be therapeutically effective for treatment of MS.

Original languageEnglish (US)
Pages (from-to)24-27
Number of pages4
JournalJournal of Neuroimmunology
StatePublished - Feb 15 2018



  • B cell
  • Lipoic acid
  • Migration
  • Monocyte
  • RRMS

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Neurology
  • Clinical Neurology

Cite this